4//SEC Filing
Bjork Elisabeth 4
Accession 0001140361-25-033017
CIK 0001281895other
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 8:54 PM ET
Size
4.6 KB
Accession
0001140361-25-033017
Insider Transaction Report
Form 4
Bjork Elisabeth
Director
Transactions
- Purchase
Common Stock
2025-08-27$3.41/sh+10,000$34,100→ 40,000 total
Footnotes (1)
- [F1]Includes 30,000 restricted stock units ("RSUs") that convert to common stock on a one-for-one basis and vest in full on June 18, 2026.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001810406
Filing Metadata
- Form type
- 4
- Filed
- Aug 26, 8:00 PM ET
- Accepted
- Aug 27, 8:54 PM ET
- Size
- 4.6 KB